HR 290 108th Congress House Health Agriculture and Food Ambulatory care Animals Clinical trials Congress Congressional investigations Congressional reporting requirements Department of Health and Human Services Digestive diseases Drug therapy Economics and Public Finance Education Environmental Protection Environmentally induced diseases Epidemiology Federal aid to research Genetic research Genetics Government Operations and Politics

Inflammatory Bowel Disease Act

Introduced: January 8, 2003 See on congress.gov

Everywhere this bill has been 3 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Feb 3, 2003

Referred to the Subcommittee on Health.

Jan 8, 2003

Referred to the House Committee on Energy and Commerce.

Jan 8, 2003

Introduced in House

Plain-English summary Congressional Research Service

Inflammatory Bowel Disease Act - Requires the Director of the National Institute of Diabetes and Digestive and Kidney Diseases to expand activities addressing inflammatory bowel disease, emphasizing genetic, animal model, and clinical research.

Requires the Director of the Centers for Disease Control and Prevention to establish a national program of prevention and epidemiology concerning such disease, addressing its prevalence and public and professional awareness.

Directs the Institute of Medicine of the National Academies of Science to study public and private insurance standards for coverage of inflammatory bowel therapies.

Directs the General Accounting Office to study problems inflammatory bowel disease patients have applying for disability insurance benefits under the Social Security Act.

What's happening now February 3, 2003

Referred to the Subcommittee on Health.

Committees of jurisdiction 2